Breaking News
November 17, 2018 - Warmer winter temperatures related to higher crime rates
November 17, 2018 - MCO places increasing emphasis on helping people find and access healthy food
November 17, 2018 - Group of students aim to improve malaria diagnosis using old smartphones
November 17, 2018 - Transplantation of feces may protect preterm children from deadly bowel disease
November 17, 2018 - Researchers explore whether low-gluten diets can be recommended for people without allergies
November 17, 2018 - New and better marker for assessing patients after cardiac arrest
November 17, 2018 - For 7-year-old with failing bone marrow, a life-saving transplant | News Center
November 17, 2018 - New first-line treatment for peripheral T-cell lymphoma approved by FDA
November 17, 2018 - Artificial intelligence could be valuable tool to help young victims disclose traumatic testimony
November 17, 2018 - Breakthrough in the treatment of Restless Legs Syndrome
November 16, 2018 - FDA Approves Keytruda (pembrolizumab) for the Treatment of Patients with Hepatocellular Carcinoma (HCC) Who Have Been Previously Treated with Sorafenib
November 16, 2018 - Eagle Books | Native Diabetes Wellness Program
November 16, 2018 - Patients with common heart failure more likely to have lethal heart rhythms
November 16, 2018 - How AI could help veterinarians code their notes | News Center
November 16, 2018 - Bias-based bullying does more harm to students than generalized bullying
November 16, 2018 - Researchers find first direct evidence that cerebellum plays role in cognitive functions
November 16, 2018 - Non-coding genetic variant plays key role in endothelial function and disease incidence
November 16, 2018 - EMA recommends first all-oral treatment to tackle deadly sleeping sickness
November 16, 2018 - Drug used to treat dizziness may slow down growth of triple-negative breast cancer
November 16, 2018 - AHA: Icosapent Ethyl Cuts CV Risk From Elevated Triglycerides
November 16, 2018 - ‘Orphan’ RNAs make cancer deadlier, but potentially easier to diagnose
November 16, 2018 - Air Cube touches down at hospital | News Center
November 16, 2018 - CRISPR-based tool shown to enhance cell-based immunotherapy
November 16, 2018 - Mechanisms that govern HIV latency differ in the gut and blood, finds study
November 16, 2018 - Researchers unravel mystery of NPM1 protein in acute myeloid leukemia
November 16, 2018 - High school students less likely to select milk, fruit for lunch when fruit juice is available
November 16, 2018 - Football coaches with great emotional competence are more successful
November 16, 2018 - Researchers awarded $10 million grant to address root causes of asthma in Puerto Rico
November 16, 2018 - Health Tip: Manage Morning Sickness
November 16, 2018 - Immunotherapy combination and chemotherapy show encouraging results in Phase II acute myeloid leukemia study
November 16, 2018 - ACC Latin America Conference brings experts to discuss latest cardiovascular science
November 16, 2018 - Pooled analysis of Intersect ENT’s steroid releasing implants in patients after frontal sinus surgery to be published
November 16, 2018 - Expectations about pain intensity can become self-fulfilling prophecies
November 16, 2018 - NIH awards $3.4 million to UC researchers to study gastrointestinal lymphatic system
November 16, 2018 - Highlighting Advances in Bioengineering and Analytical Technologies with eBooks
November 16, 2018 - Scientist Dr David Taylor of MR Solutions is a finalist in the BMW i UK Tech Founder Awards
November 16, 2018 - Earlier treatment could help reverse autistic-like behavior in tuberous sclerosis
November 16, 2018 - Sucking your baby’s pacifier could improve their health
November 16, 2018 - Vegetables and salad may include bacteria that are resistant to antibiotics
November 16, 2018 - Autism linked to prolonged connection between brain regions
November 16, 2018 - Endocrine Society chooses four Diabetes Caucus leaders as winners of Diabetes Champion Award
November 16, 2018 - Brain and muscle cells found within kidney organoids
November 16, 2018 - Person’s sex hormones may play key role in trauma survival, finds study
November 16, 2018 - PTEN Genetic Test: MedlinePlus Lab Test Information
November 16, 2018 - Toxic metal pollution linked with development of autism spectrum disorder
November 16, 2018 - Calcified nodules in the retina increase risk for progression to late stages of AMD
November 16, 2018 - ZEISS teams up with arivis AG to offer complete 3D imaging solutions
November 16, 2018 - Georgia State professor receives $1.2 million grant to study how the brain controls eating behavior
November 16, 2018 - Specific bacterial toxins reduce number of cells suppressing immune response
November 16, 2018 - Review by ID physician improves outcomes for outpatient parenteral antimicrobial therapy
November 16, 2018 - Conditions that produce signs similar to arthritis
November 16, 2018 - New artificial intelligence-based method predicts treatment effectiveness
November 16, 2018 - AHA: Dapagliflozin Noninferior to Placebo for MACE in T2DM
November 16, 2018 - Surgery remains best treatment for appendicitis, Stanford study finds
November 16, 2018 - Non-surgical fistula creation system Ellipsys becomes key focus of attention at CiDA
November 16, 2018 - Researchers find no link between ‘allergy friendly’ dogs and lower risk of asthma
November 16, 2018 - Researchers elucidate new rules of connectivity of neurons in the neocortex
November 16, 2018 - Treating children with ‘bubble baby disease’
November 16, 2018 - Nexus announces availability of Arsenic Trioxide Injection in the US
November 16, 2018 - Researchers find metabolite shuttle between cells in the liver that may combat tissue fibrosis
November 16, 2018 - AHA: PTSD Common Among Those Who Suffer Tear in the Aorta’s Wall
November 16, 2018 - Many RA patients’ pain related to central nervous system
November 16, 2018 - Changes in Himalayan gut microbiomes linked to diet
November 16, 2018 - Inhibition of prostaglandin E2 enhances ability to combat infectious colitis
November 16, 2018 - Chronic dry eye can slow reading rate and disrupt day to day tasks
November 16, 2018 - Researchers develop new drug molecule that inhibits inflammation
November 16, 2018 - Dementia symptoms peak in winter and spring, study finds
November 16, 2018 - Stanford tobacco researcher weighs in on JUUL
November 16, 2018 - Increasing omega-3 fatty acid intake during pregnancy reduces risk of premature birth, review finds
November 16, 2018 - Researchers find no link between infants waking up at night and later developmental problems
November 16, 2018 - Both parents and children agree about confidential medical services
November 16, 2018 - FDA warns against use of unapproved pain medications with implanted pumps
November 16, 2018 - Precision medicine-based approach to slow or reverse biologic drivers of Alzheimer’s disease
November 16, 2018 - Study provides new insight into norovirus outbreaks, may help guide efforts to develop vaccines
November 16, 2018 - Inexpensive, portable air purifier could help protect the heart from pollution
November 16, 2018 - New 15-minute scan could help diagnose brain damage in babies up to two years old
November 16, 2018 - Deep brain stimulation not effective for treating early Alzheimer’s
November 16, 2018 - Traditional chemotherapy superior to new alternative for oropharyngeal cancers | News Center
November 16, 2018 - What This Pond Protist Does With Its Genome Will Astound You
November 15, 2018 - Researchers develop tool that speeds up analysis and publication of biomedical data
The latest ECG device from Schiller

The latest ECG device from Schiller

image_pdfDownload PDFimage_print

With the launch of CARDIOVIT AT-102 G2, SCHILLER is releasing the latest generation of ECG devices.  

In the CARDIOVIT AT-102 G2 we have implemented our many years of experience, customer wishes and optimization possibilities. Our developers have used the latest and best technologies. The device makes a quantum leap in electrocardiography in one fell swoop“.

Dr. Michela Perrini, Global Product Manager at SCHILLER in Baar, Switzerland

The first 300 units CARDIOVIT AT-102 G2 have already been shipped. The decision makers of Mehiläinen in Finland reveal the devices key qualities they wanted to adopt in their nationwide institution.

The Swiss medical engineering company SCHILLER launches the latest generation in electrocardiography for hospitals, clinics and medical practices.

CARDIOVIT AT-102 G2 features state of-the-art technology, extremely high operation speed, ease of use, and bi-directional WiFi communication to implement the patient data and send the ECG.

The CARDIOVIT AT-102 G2 is equipped with an 8-inch HD colour display for quick and effective ECG review. The screen has touch function keys, which, together with the navigation keys, allow a very fast device operation.

Simplifying the daily clinic life

The sophisticated hardware and software make CARDIOVIT AT-102 G2 very fast. The device’s internal memory can accommodate several hundred ECGs. If a record is to be transmitted to an EPA / HIS/ PACS system by WiFi, this can be done in less than a second.

This task is what appreciates one of the first customers that bought five units of CARDIOVIT AT-102 G2: Mehiläinen, a nationwide provider of healthcare services in Finland.

Finnish national recommendations are going to DICOM ECG. So we are updating our ecg process as well as archiving systems. Our long, good and reliable cooperation and experience with SCHILLER systems and devices gave faith in continuity.”

Kristina Hotakainen, Director of laboratory services at Mehiläinen Oy

CARDIOVIT AT-102 G2 will be connected with the Mehiläinen Carestream PACS system through the new SCHILLER SEMA.

“The automated DICOM workflow is easy and needs a minimum of manual entries,” said Matti Pekka Räsänen, Mehiläinen IT Service Engineer

Fast reliable connectivity in the new workflow with minimum manual work in data recording was an important feature for the Mehiläinen decision makers. Paperless fast recording is easy and effective for the Mehiläinen laboratories and occupational nurses.

High speed for greatest efficiency

“In particular, the very fast and very simple operation was a main customer requirement. With CARDIOVIT AT-102 G2, we were able to bring today’s state of the art into medical technology – not an easy task, but we succeeded,” says Dr. Michela Perrini, Global Product Manager at SCHILLER.

Using only one navigation key and in three short steps, it is possible to download the patient data via PDQ or work list, to record the ECG, and then to save, print and transmit the data. The device supports paperless workflows, which saves costs.

When a paper report is needed, custom printouts can be made from the internal full sized (A4), high-resolution thermal printer. The long battery life makes a single battery charge sufficient for eight hours of ECG recordings during the labour-intensive clinical routine. In addition, CARDIOVIT AT-102 G2 is robust and reliable.

The alphanumeric keyboard is sealed and easy to clean, making it easier to comply with the strict hospital hygiene requirements. The trolley’s smoothly running wheels and a handle at the optimum height allows comfortable moving and working. With the standardly mounted storage basket, all important accessories are always at hand.

Proven SCHILLER quality

With its latest innovation, SCHILLER has developed an impressive ECG device with many new features that far exceed the high requirements in the healthcare sector. The body illustration on the large screen shows the exact electrode placement for different configurations. A new function indicates when electrodes have been connected incorrectly.

CARDIOVIT AT-102 G2 has highest signal quality, which is especially important for paediatric ECGs. The automatic interpretation provides a reliable analysis of the ECG for both children and adults.

Three software options complete CARDIOVIT AT-102 G2: Stress ECG, ETM Sport for the automatic interpretation of the athlete’s heart and CCAA (Culprit Coronary Artery Algorithm).

From a one-man operation to the world’s leading ECG supplier

Company founder Alfred Schiller started his company with ECG devices in the 1970s. To date, a variety of device types have been developed.

SCHILLER is one of the world’s leading developers and suppliers of cardiac diagnostics. Currently, more than a dozen ECG devices are available, with special features depending on customer needs, location or the desired accessories.

CARDIOVIT AT-102 G2 is the latest electrocardiography product. It is CE approved. The CARDIOVIT AT-102 G2 is produced at the SCHILLER headquarters in Baar, Switzerland.

Tagged with:

About author

Related Articles